Latest News

Origins sponsors the PMEA award for Excellence in Patient Education and Support

Origins sponsors the PMEA award for Excellence in Patient Education and Support

[16 November 2022]

Origins is proud to sponsor this year’s PMEA award for Excellence in Patient Education and Support. This award highlights the importance of the patient within today’s healthcare environment…

More “Origins sponsors the PMEA award for Excellence in Patient Education and Support”

Origins delivers ‘valuable’ and ‘insightful’ BHBIA webinar

Origins delivers ‘valuable’ and ‘insightful’ BHBIA webinar

[15 November 2022]

As active members of the BHBIA (British Healthcare Business Intelligence Association), Origins was honoured to host a recent educational webinar entitled “Improving health care by understanding patient sentiment & preference”.

It has long been known that if healthcare providers obtain an understanding of patients’ preferences relating to their care & treatment, then better decisions can be made. But how can pharma better understand patient sentiment and preferences, and why would they want to..?

More “Origins delivers ‘valuable’ and ‘insightful’ BHBIA webinar”

Mark Corbett explains why Origins is evolving

Mark Corbett explains why Origins is evolving

[14 November 2022]

Resonant Group Chief Innovation Officer, Mark Corbett has released a video explain why Origins is evolving from a Patient Insights agency to a Patient Focused Specialist agency.

To watch the video please visit the Knowledge Centre section of this website and it can be found under ‘Our team talking about our work’. Whilst you are there, why not check out some of our other videos, articles and recording of our highly successful webinar series.

Origins Insights Evolves Into Patient Specialist Agency

Deeper focus on patient engagement across the pharma/biotech product lifecycle

[1 November 2022] –  Origins Insights, a Resonant Group company, today announced the evolution of its unique service offering to become an exclusively patient focused agency. 

 “Historically, the significant potential contribution of patients to the pre-clinical and clinical investigation of new therapies has been under-recognised,” said Mark Corbett, Chief Innovation Officer, Resonant Group, who will lead the new offering. “Our evolved suite of services builds on our ability to access deep patient insights at all stages of the drug lifecycle, from clinical development, through market access into commercialisation.” 

More “Origins Insights Evolves Into Patient Specialist Agency”